Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT05147233 | A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery | PHASE3 | COMPLETED | 241 | — | — | Jun 1, 2022 | Jul 1, 2023 | Jul 10, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| OCS-01 | DRUG | Dexamethasone ophthalmic suspension, 1.5% |
| Vehicle | DRUG | Vehicle |